Health Canada has approved a new drug treatment for adults living with Fabry disease, a rare genetic disorder that can affect multiple organs and impact the quality of life.
An FDA panel of experts has called for a loosening of regulations and expanding access to testosterone replacement therapy.
Elfabrio® (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult ...
A parliamentary forum has urged urgent action on funding shortfalls and treatment delays for patients with Lysosomal Storage ...
The Indian Medical Parliamentarians’ Forum (IMPF), a cross-party collective of 45 medical professionals turned ...
The Indian Medical Parliamentarians Forum (IMPF) — ?a cross-party group of 45 MPs who are also medical professionals — ?has ...
The Indian Medical Parliamentarians’ Forum (IMPF), a group of 45 members of parliament who are also medical professionals, ...
The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.
Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback